Mirum Pharmaceuticals (MIRM) Long-Term Investments (2019 - 2026)

Mirum Pharmaceuticals' Long-Term Investments history runs 6 years deep, the most recent figure standing at $34.4 million for Q1 2026.

• In Q1 2026, Long-Term Investments rose 64.27% year-over-year to $34.4 million; the TTM figure through Mar 2026 stood at $34.4 million (up 64.27% YoY), while the FY2025 annual figure was $8.1 million, down 35.29% from the prior year.
• Long-Term Investments was $34.4 million for Q1 2026 at Mirum Pharmaceuticals, up from $8.1 million in the prior quarter.
• In the past five years, Long-Term Investments ranged from a high of $34.4 million in Q1 2026 to a low of $2.5 million in Q3 2025.
• Historically, Long-Term Investments has averaged $15.2 million across 3 years, with a median of $14.8 million in 2024.
• The sharpest annual moves came in 2025 and 2026: Long-Term Investments plunged 73.5% in 2025, then surged 64.27% in 2026.
• A 3-year view of Long-Term Investments shows it stood at $12.5 million in 2024, then sank by 35.29% to $8.1 million in 2025, then surged by 323.85% to $34.4 million in 2026.
• The last three Long-Term Investments figures came in at $34.4 million (Q1 2026), $8.1 million (Q4 2025), and $2.5 million (Q3 2025), per Business Quant data.